Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer

Clinical trial NCT02785939 · COMPLETED

Trial details

NCT number: NCT02785939
Sponsor: SWOG Cancer Research Network
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

CCND1 Gene Amplification CCND2 Gene Amplification CCND3 Gene Amplification CDK4 Gene Amplification Recurrent Squamous Cell Lung Carcinoma Stage IV Squamous Cell Lung Carcinoma AJCC v7

Start date: 2014-09-01
Primary completion: 2017-06-01
Enrollment: 53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.